SCHEMBL1745299

SCHEMBL1745299

O=C(O)CCc1ccc(OCc2ccc(CNCc3ccc(Oc4ccccc4)cc3)cc2)cc1

nearest known ligand 0.84

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 15/20 0.84
FFAR4 Q5NUL3 6/20 0.84
BCHE P06276 2/20 0.61
SRD5A2 P31213 1/20 0.60
AKR1B1 P15121 1/20 0.57
POLB P06746 1/20 0.57
TDP1 Q9NUW8 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1747385 0.93 FFAR1 (0.80) FFAR1FFAR4BCHEAKR1B1TDP1
SCHEMBL1744943 0.92 FFAR1 (1.00) FFAR1FFAR4SRD5A2AKR1B1
SCHEMBL1747130 0.92 FFAR1 (1.00) FFAR1FFAR4SRD5A2AKR1B1
SCHEMBL1746714 0.90 FFAR1 (0.84) FFAR1FFAR4BCHEAKR1B1POLB
SCHEMBL1747433 0.89 FFAR1 (0.94) FFAR1FFAR4SRD5A2AKR1B1POLB
SCHEMBL13686585 0.87 BCHE (0.79) FFAR1FFAR4BCHEAKR1B1
SCHEMBL2772440 0.86 FFAR1 (1.00) FFAR1FFAR4AKR1B1
SCHEMBL1747197 0.85 FFAR1 (0.91) FFAR1FFAR4SRD5A2AKR1B1
Benzyloxyphenylpropanoic Acid SCHEMBL1134648 0.84 FFAR1 (1.00) FFAR1FFAR4AKR1B1POLBTDP1
SCHEMBL1744939 0.84 FFAR1 (1.00) FFAR1FFAR4AKR1B1POLBTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1559422-B1 RECEPTOR FUNCTION CONTROLLING AGENT TAKEDA PHARMACEUTICAL (JP) 2014-04-30 EP disclosed
EP-2385032-A1 GPR40 Receptor function regulator Takeda Pharmaceutical Company Limited (JP) 2011-11-09 EP disclosed
EP-2385032-A1 GPR40 Receptor function regulator Takeda Pharmaceutical Company Limited (JP) 2011-11-09 EP disclosed
US-7960369-B2 Receptor function regulator TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-06-14 US disclosed
US-7960369-B2 Receptor function regulator TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-06-14 US disclosed
US-7960369-B2 Receptor function regulator TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-06-14 US disclosed
US-20090012093-A1 Receptor Function Regulator TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-01-08 US disclosed
US-20090012093-A1 Receptor Function Regulator TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-01-08 US disclosed
US-20090012093-A1 Receptor Function Regulator TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-01-08 US disclosed
EP-1559422-A1 RECEPTOR FUNCTION CONTROLLING AGENT Takeda Pharmaceutical Company Limited (JP) 2005-08-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090012093-A1 Receptor Function Regulator GPR119, GIPR, INSR FFAR1 33/4885FFAR4 44/4885BCHE 4093/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.